Clinical Trial

Study of XmAb412 in Healthy Participants

Name: Study of XmAb412 in Healthy Participants — clinical trial record (NCT07713485)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This Phase 1 Study will evaluate the safety, tolerability, pharmacokinectics and pharmacodynamics of XmAb412 in healthy adult participants

Trial Details

NCT Number	NCT07713485
Lead Sponsor	Xencor, Inc.
Conditions	Not Applicable - Healthy Adult Participants
Enrollment	128 participants
Start Date	2026-07-13
Primary Completion	2027-05 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-03